Seer Board Rejects $2.35 Per Share Buyout Offer from Radoff-JEC Group
Event summary
- The Radoff-JEC Group, owning 7.6% of Seer, Inc., offered $2.35 per share in cash plus a contingent value right, rejected by the Seer Board.
- The offer represents a 39% premium over Seer’s unaffected stock price and includes an asset monetization plan.
- Seer’s Board cited confidence in its strategy but has faced criticism for negligible growth and $465 million in cumulative losses under CEO Omid Farokhzad.
- Radoff-JEC Group plans to nominate three new directors at Seer’s 2026 Annual Meeting, aiming to hold the incumbent board accountable.
The big picture
The rejection of the Radoff-JEC Group’s offer highlights a broader tension between activist investors and incumbent boards in the biotech sector. Seer’s struggles, including significant stock price declines and cumulative losses, underscore the challenges faced by companies with unproven platforms and leadership under scrutiny. The outcome of this proxy battle could set a precedent for governance shifts in similar firms.
What we're watching
- Governance Dynamics
- Whether the Radoff-JEC Group can successfully nominate new directors and influence Seer’s strategic direction.
- Execution Risk
- The pace at which Seer can demonstrate tangible progress under its current leadership to regain investor confidence.
- Market Reaction
- How the market will respond to the ongoing proxy battle and potential changes in Seer’s board composition.
Related topics